Gastrointestinal adverse events, primarily nausea, vomiting, diarrhea, and constipation, are the predominant side effects, occurring most frequently during dose escalation and generally diminishing with continued treatment
Successful integration of GLP-1 medications into your life begins with thoughtful scheduling
Drawing on her years of experience as a former plan sponsor and pharmacy director, Bridget unpacks the reality of modern PBM contracts, breaks down why lower rebates can actually be a positive signal for plan sponsors, how the biosimilar pipeline is reshaping the market, and what to watch out for as GLP-1 medications expand their indications
The American Diabetes Association (ADA) recognizes the cardiovascular benefits of GLP-1 receptor agonists in their Standards of Care but does not currently recommend these agents solely for inflammation management outside established indications for diabetes, obesity, or cardiovascular risk reduction
International Journal of Pharmaceutical Compounding
Boosts Collagen Production: Packed with GHK-Cu's skin-rejuvenating benefits, AnagenX also makes an excellent addition to your skincare routine